Piper Sandler Has Lowered Expectations for Edap Tms (NASDAQ:EDAP) Stock Price

Edap Tms (NASDAQ:EDAP) had its price objective reduced by stock analysts at Piper Sandler from $5.00 to $4.50 in a note issued to investors on Friday,Benzinga reports. The firm presently has an “overweight” rating on the medical equipment provider’s stock. Piper Sandler’s price target would suggest a potential upside of 109.30% from the company’s current price.

A number of other analysts also recently issued reports on EDAP. StockNews.com assumed coverage on Edap Tms in a research report on Friday. They issued a “hold” rating for the company. HC Wainwright reissued a “buy” rating and issued a $19.00 price objective on shares of Edap Tms in a report on Friday.

Edap Tms Stock Down 3.2 %

Shares of NASDAQ:EDAP opened at $2.15 on Friday. Edap Tms has a 1 year low of $1.96 and a 1 year high of $8.50. The company has a market capitalization of $79.77 million, a PE ratio of -3.31 and a beta of 0.37. The business has a fifty day moving average price of $2.42 and a two-hundred day moving average price of $2.50. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46.

Edap Tms (NASDAQ:EDAP) last posted its quarterly earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.11) by $0.06. The company had revenue of $22.69 million during the quarter, compared to analyst estimates of $20.83 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. Analysts forecast that Edap Tms will post -0.6 earnings per share for the current year.

Institutional Investors Weigh In On Edap Tms

Hedge funds and other institutional investors have recently bought and sold shares of the business. Illumine Investment Management LLC purchased a new position in shares of Edap Tms in the fourth quarter valued at $50,000. BNP Paribas Financial Markets grew its holdings in Edap Tms by 23.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock valued at $59,000 after buying an additional 4,400 shares in the last quarter. Jane Street Group LLC increased its position in shares of Edap Tms by 174.7% during the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock valued at $69,000 after buying an additional 73,361 shares during the period. Millennium Management LLC boosted its position in shares of Edap Tms by 218.5% in the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock valued at $108,000 after acquiring an additional 33,558 shares during the period. Finally, Orion Capital Management LLC grew its stake in Edap Tms by 10.4% during the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock valued at $178,000 after acquiring an additional 6,600 shares in the last quarter. Institutional investors own 62.74% of the company’s stock.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.